NCT01035411View on ClinicalTrials.gov

AZD9668 Relative Bioavailability

PHASE1CompletedINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

AZD9668

2 x 30 mg batch DLE494

DRUG

AZD9668

2 x 30 mg batch DLF497

DRUG

AZD9668

2 x 30 mg tablet variant 1

Trial Locations (1)

Unknown

Research Site, Berlin

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY